Adaptive Biotechnologies Corporation (ADPT) vs RadNet, Inc. (RDNT)
- Adaptive Biotechnologies Corporation ADPT 24.02 −6.10%
- RadNet, Inc. RDNT 68.53 −2.67%
Adaptive Biotechnologies Corporation and RadNet, Inc. are both Diagnostics & Research companies. RadNet, Inc. is the larger, with a market value of $5.5B against $4.1B — 1.4× the size. Adaptive Biotechnologies Corporation grew revenue faster over the last twelve months: 50.1% against 18.9%. RadNet, Inc. has the higher net margin (−0.93% vs −20.7%) and the higher return on invested capital (2.24% vs −16.6%). Across the 18 metrics below, RadNet, Inc. leads on 13 and Adaptive Biotechnologies Corporation on 5.
Valuation
Profitability
| Metric | ADPT | RDNT | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 75.57% | 11.53% | 50.89% |
| Operating margin | (12.16%) | 3.12% | (8.57%) |
| Net margin | (20.73%) | (0.93%) | (6.37%) |
| Free cash flow margin | (7.80%) | 3.28% | 0.00% |
| Return on equity | (38.68%) | (1.64%) | (2.92%) |
| Return on assets | (11.23%) | (0.55%) | (6.71%) |
| Return on invested capital | (16.57%) | 2.24% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack